6-month drug regimen ‘reduces HIV risk for breastfeeding infants’
March 3rd, 2011 - 2:55 pm ICT by ANIWashington, Mar 3 (ANI): In a new study, scientists found that giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks.
The longer nevirapine regimen achieved a 75 percent reduction in HIV transmission risk through breast milk for the infants of HIV-infected mothers with higher T-cell counts who had not yet begun treatment for HIV.
“Extended breastfeeding reduces infant mortality in places that lack safe, clean water by protecting babies from common childhood diseases because breast milk contains protective antibodies from the mother that formula feeding does not provide,” says Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, which funds the trial.
“These findings show that giving the infants of HIV-infected mothers an antiretroviral drug daily for the full duration of breastfeeding safely minimizes the threat of HIV transmission through breast milk while preserving the health benefits of extended breastfeeding.”
The new findings apply to mothers and infants in developing nations, where infectious diseases such as gastroenteritis and pneumonia often pose a life-threatening risk to very young children.
The study was presented at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on March 2, 2011. (ANI)
- Breast milk antibodies help neutralize HIV - May 23, 2012
- New HIV/AIDS study could turn treatment 'on its head' - Mar 04, 2011
- Daily antiretroviral therapy may prevent mother-to-child HIV transmission - Jul 23, 2009
- Vitamin A makes breastfeeding with HIV more risky: Study - Aug 27, 2010
- Longer breastfeeding protects kids born to HIV-infected mums - Jan 15, 2010
- HAART may help reduce mother-to-child HIV transmission - Aug 02, 2009
- Early testing, treatment dramatically prevents illness, death in HIV-positive babies - Nov 20, 2008
- HIV drug given to protect foetus should be avoided after childbirth for 1yr - Feb 26, 2010
- Trials to test H1N1 vaccine efficacy in HIV-infected pregnant women underway - Oct 10, 2009
- Breastfeeding can benefit even the sickest babies - Oct 28, 2010
- Female-to-male HIV transmission risk doubles during pregnancy: Study - May 24, 2010
- AIDS drugs block 99pc of HIV transmission to breastfed babies - Jun 17, 2010
- Common parasite linked to severe birth defects - Apr 15, 2012
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- Drug reduces HIV transmission through breastfeeding - Feb 05, 2008
Tags: anthony s fauci, antiretroviral drug, breast milk, common childhood diseases, conference on retroviruses, conference on retroviruses and opportunistic infections, developing nations, drug regimen, gastroenteritis, health benefits, hiv risk, hiv transmission, infant mortality, infectious diseases, national institute of allergy and infectious diseases, national institutes of health, nevirapine, protective antibodies, risk of hiv, t cell